This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Protalix Ltd., Hadasit Medical Research Services and Development Ltd., Technion Research & Development Foundation Ltd. Active years: 2021-2026.
Company Filing History:
2 out of 27 
1 out of 181 
1 out of 1,003 
Years Active: 2021-2026
Title: Gil Arvatz: Innovator in Uric Acid Treatment
Introduction
Gil Arvatz is a notable inventor based in Kfar Tavor, Israel. He has made significant contributions to the field of medicine, particularly in the treatment of diseases associated with elevated uric acid levels. With a total of 3 patents to his name, Arvatz has established himself as a key figure in medical innovation.
Latest Patents
Among his latest patents, Arvatz has developed methods for treating diseases associated with elevated uric acid. His work on modified uricase and its various uses has the potential to impact the treatment landscape for patients suffering from related conditions.
Career Highlights
Throughout his career, Gil Arvatz has worked with prominent organizations such as Protalix Ltd. and Technion Research & Development Foundation Ltd. His experience in these institutions has allowed him to advance his research and contribute to significant medical advancements.
Collaborations
Arvatz has collaborated with talented individuals in his field, including Ilya Ruderfer and Yakir Nataf. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Gil Arvatz is a distinguished inventor whose work in treating diseases related to elevated uric acid showcases his commitment to medical innovation. His contributions continue to influence the field and improve patient outcomes.